Health-related quality of life in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in a naturalistic outpatient setting

PURPOSE: To assess the levels of quality of life (QoL) in major depressive disorder (MDD) patients treated with either duloxetine or a selective serotonin reuptake inhibitor (SSRI) as monotherapy for up to 6 months in a naturalistic clinical setting mostly in the Middle East, East Asia, and Mexico....

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Patient Prefer Adherence
Hlavní autoři: Hong, Jihyung, Novick, Diego, Montgomery, William, Moneta, Maria Victoria, Dueñas, Héctor, Peng, Xiaomei, Haro, Josep Maria
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2015
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4621215/
https://ncbi.nlm.nih.gov/pubmed/26527865
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S89870
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky